A Clinical Trial to Evaluate the Safety and Efficacy of Olanzapine Titration Schedule in Patients With Schizophrenia

This clinical trial evaluates a gradual (titrated) low-dose starting schedule of olanzapine, an antipsychotic medication, for people with schizophrenia where a lower-than-usual starting dose is considered safer by the treating doctor. **You may be eligible if...** - You have been diagnosed with schizophrenia (according to DSM-5 criteria) for more than 1 year - Your doctor judges that a lower starting dose of olanzapine is more appropriate for you than the standard dose **You may NOT be eligible if...** - You have a different psychotic or mood disorder (such as schizoaffective disorder, bipolar disorder, or depression) - You have serious medical conditions that contraindicate olanzapine use - You are pregnant or breastfeeding - You have had no response to olanzapine in the past Talk to your doctor to see if this trial is right for you.